Klotho Neurosciences, Inc. Common Stock (KLTO) is a publicly traded Healthcare sector company. As of May 21, 2026, KLTO trades at $0.52 with a market cap of $56.66M and a P/E ratio of -2.36. KLTO moved -0.20% today. Year to date, KLTO is -2.66%; over the trailing twelve months it is +85.36%. Its 52-week range spans $0.11 to $3.91. Rallies surfaces KLTO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Klotho Neurosciences to Acquire $68B Greenland Palladium-Gold Project for 93% Stake: Klotho Neurosciences is acquiring Greenland Mines Corp, gaining an 80% interest (with option on remaining 20%) in the Skaergaard Project housing 25.4 Moz PdEq and 23.5 Moz AuEq valued at about $68 billion. Post-deal, former Greenland stakeholders will hold roughly 93% of the combined convertible shares.
| Metric | Value |
|---|---|
| Price | $0.52 |
| Market Cap | $56.66M |
| P/E Ratio | -2.36 |
| EPS | $-0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.91 |
| 52-Week Low | $0.11 |
| Volume | 2.35M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.55M |
| Gross Margin | 0.00% |
KLTO analyst coverage data. Average price target: $0.00.